Read and download the financial news from NFL Biosciences. To receive our announcements directly in your mailbox subscribe to our mailing list.
June 30, 2021 • Success of the IPO on Euronext Growth Paris
June 16, 2021 • NFL Biosciences launches its initial public offering on Euronext Growth Paris (in French only)
June 2, 2021 • French smoking cessation innovation approved for Phase II clinical trial (in French only)